Hans Prenen Selected Research

Hans Prenen Research Topics

Disease

41	Neoplasms (Cancer) 07/2022 - 02/2005
27	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2009
14	Neoplasm Metastasis (Metastasis) 02/2021 - 12/2010
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2008 - 02/2005
4	Inflammation (Inflammations) 07/2022 - 08/2013
4	Adenocarcinoma 01/2021 - 10/2012
3	Disease Progression 01/2022 - 05/2019
3	Hypoxia (Hypoxemia) 01/2021 - 01/2012
3	Fatigue 01/2021 - 01/2016
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 01/2017
2	Pain (Aches) 07/2022 - 12/2017
2	Body Weight (Weight, Body) 07/2022 - 01/2020
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2011
2	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 10/2012
2	Fever (Fevers) 11/2020 - 01/2016
1	Cardiotoxicity 07/2022
1	Coronary Disease (Coronary Heart Disease) 07/2022
1	Myocarditis (Carditis) 07/2022
1	Cholangiocarcinoma 07/2022
1	Wasting Syndrome (Wasting Disease) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cachexia 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Microsatellite Instability 03/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hepatitis 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2021
1	Abdominal Obesity 01/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	Hypertension (High Blood Pressure) 11/2020

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 10/2021 - 05/2009
9	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2015
8	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2009
6	ErbB Receptors (EGF Receptor)IBA 10/2021 - 05/2009
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 05/2009
6	Imatinib Mesylate (Gleevec)FDA Link 09/2008 - 02/2005
5	Phosphotransferases (Kinase)IBA 01/2019 - 03/2006
4	Tyrosine Kinase InhibitorsIBA 07/2022 - 01/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
4	Panitumumab (Vectibix)FDA Link 10/2021 - 08/2014
3	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 02/2021 - 08/2013
3	Sunitinib (Sutent)FDA Link 11/2015 - 04/2006
3	Biological ProductsIBA 08/2013 - 12/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 12/2010
2	IronIBA 01/2022 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 10/2012
2	Messenger RNA (mRNA)IBA 01/2020 - 05/2019
2	regorafenibIBA 01/2019 - 01/2016
2	afliberceptIBA 01/2019 - 10/2012
2	Epidermal Growth Factor (EGF)IBA 06/2017 - 12/2011
2	MTOR InhibitorsIBA 11/2016 - 01/2009
2	AntibodiesIBA 10/2014 - 12/2010
2	Cetuximab (Erbitux)FDA Link 01/2013 - 05/2009
2	Sorafenib (BAY 43-9006)FDA Link 01/2009 - 09/2008
2	nilotinib FDA Link 09/2008 - 01/2006
2	Protein Isoforms (Isoforms)IBA 09/2008 - 04/2006
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2008 - 04/2006
1	SteroidsIBA 07/2022
1	IpilimumabIBA 07/2022
1	Prednisolone (Predate)FDA LinkGeneric 07/2022
1	TroponinIBA 07/2022
1	NivolumabIBA 07/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	sotorasibIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	NitrogenIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	budigalimabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	rovalpituzumab tesirineIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	LY3300054IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	IDO-1 inhibitor LY3381916IBA 01/2021
1	Transaminases (Aminotransferases)IBA 11/2020
1	CytokinesIBA 09/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2020

Therapy/Procedure

27	Therapeutics 07/2022 - 05/2008
16	Drug Therapy (Chemotherapy) 10/2018 - 08/2006
4	Microspheres (Microsphere) 11/2020 - 01/2016
3	Neoadjuvant Therapy 01/2021 - 05/2019
2	Immunotherapy 03/2021 - 01/2020
2	Radiotherapy 09/2020 - 09/2015
2	Catheters 07/2020 - 06/2016
2	Precision Medicine 01/2020 - 12/2019
2	Salvage Therapy 01/2016 - 01/2013
1	Stem Cell Transplantation 01/2022
1	Chemoradiotherapy 01/2021
1	Organ Sparing Treatments 01/2021